{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:27:49Z","timestamp":1787016469829,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1124\/jpet.111.188425","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T21:25:12Z","timestamp":1319750712000},"page":"286-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Effects of the \u03b12-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers"],"prefix":"10.1016","volume":"340","author":[{"given":"C\u00e9dric M.","family":"Hysek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda D.","family":"Simmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Bruggisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grouzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius C.","family":"Hoener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.188425_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01061368","article-title":"Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects","volume":"23","author":"Anavekar","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.111.188425_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(88)90056-8","article-title":"Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites","volume":"149","author":"Battaglia","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.188425_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0706320","article-title":"Role of \u03b12A-adrenoceptors in the effects of MDMA on body temperature in the mouse","volume":"146","author":"Bexis","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188425_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0074-7742(08)60691-1","article-title":"Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters","volume":"33","author":"Buccafusco","year":"1992","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.111.188425_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0022-3565(25)09588-6","article-title":"Role of medullary I1-imidazoline and \u03b12-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats","volume":"273","author":"Buccafusco","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188425_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbb.2007.11.003","article-title":"Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems","volume":"89","author":"Carey","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.111.188425_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.128.3.280","article-title":"The SCL-90 and the MMPI: a step in the validation of a new self-report scale","volume":"128","author":"Derogatis","year":"1976","journal-title":"Br J Psychiatry"},{"issue":"Suppl 2","key":"10.1124\/jpet.111.188425_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/jpet.111.188425_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/clpt.2009.62","article-title":"Cannabis coadministration potentiates the effects of \u201cecstasy\u201d on heart rate and temperature in humans","volume":"86","author":"Dumont","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.111.188425_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0269881106063271","article-title":"A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers","volume":"20","author":"Dumont","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.111.188425_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0022-3565(25)12477-4","article-title":"Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla","volume":"253","author":"Ernsberger","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188425_bib12","series-title":"Das Freiburger Pers\u00f6nlichkeitsinventar (FPI)","author":"Fahrenberg","year":"1984"},{"key":"10.1124\/jpet.111.188425_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.107.129056","article-title":"Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics","volume":"323","author":"Farr\u00e9","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188425_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0006-8993(94)91570-9","article-title":"Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment","volume":"654","author":"Florin","year":"1994","journal-title":"Brain Res"},{"key":"10.1124\/jpet.111.188425_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02246288","article-title":"Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or \u201cEcstasy\u201d)","volume":"119","author":"Green","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bja\/86.1.5","article-title":"Sedative, analgesic and cognitive effects of clonidine infusions in humans","volume":"86","author":"Hall","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.111.188425_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuropharm.2011.03.028","article-title":"High concentrations of MDMA (\u201cecstasy\u201d) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells","volume":"61","author":"Hondebrink","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.188425_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.111.188425_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/emj.2009.079905","article-title":"Effects of a \u03b2-blocker on the cardiovascular response to MDMA (ecstasy)","volume":"27","author":"Hysek","year":"2010","journal-title":"Emerg Med J"},{"key":"10.1124\/jpet.111.188425_bib20","series-title":"Die Eigenschaftsw\u00f6rterliste","author":"Janke","year":"1978"},{"key":"10.1124\/jpet.111.188425_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-011-2230-7","article-title":"Clonidine blocks stress-induced craving in cocaine users","volume":"218","author":"Jobes","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00609752","article-title":"Pharmacokinetics and side-effects of clonidine","volume":"13","author":"Ker\u00e4nen","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.111.188425_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/JCP.0b013e31817ef470","article-title":"Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration","volume":"28","author":"Kolbrich","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.111.188425_bib24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.bjp.0702875","article-title":"Investigation of the prejunctional \u03b12-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens","volume":"128","author":"Lavelle","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188425_bib25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1055\/s-2003-39975","article-title":"[\u201cEcstasy\u201d (MDMA): pharmacology, toxicology, and treatment of acute intoxication.]","volume":"128","author":"Liechti","year":"2003","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1124\/jpet.111.188425_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib27","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"Meibohm","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.111.188425_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10557-005-6890-6","article-title":"Clonidine lowers blood pressure by reducing vascular resistance and cardiac output in young, healthy males","volume":"19","author":"Mitchell","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/jpet.111.188425_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/clpt.2011.125","article-title":"A perhaps unexpected role of norepinephrine in actions of MDMA","volume":"90","author":"Newton","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.111.188425_bib30","doi-asserted-by":"crossref","first-page":"R287","DOI":"10.1152\/ajpregu.00123.2002","article-title":"Physiological significance of \u03b12-adrenergic receptor subtype diversity: one receptor is not enough","volume":"283","author":"Philipp","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.111.188425_bib31","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1172\/JCI113227","article-title":"Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics","volume":"80","author":"Porchet","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.111.188425_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","article-title":"A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters","volume":"39","author":"Robertson","year":"2009","journal-title":"Mol Neurobiol"},{"key":"10.1124\/jpet.111.188425_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.188425_bib34","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","article-title":"The molecular mechanism of \u201cecstasy\u201d [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release","volume":"89","author":"Rudnick","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.188425_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1008931926181","article-title":"The Symptom Check-List-90-R (SCL-90-R): a German validation study","volume":"9","author":"Schmitz","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1124\/jpet.111.188425_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200544060-00006","article-title":"Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe","volume":"44","author":"Segura","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.111.188425_bib37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.111.188425_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.biopsych.2011.06.010","article-title":"\u03b12 Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking","volume":"70","author":"Smith","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.188425_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/00952990903383961","article-title":"Atomoxetine attenuates dextroamphetamine effects in humans","volume":"35","author":"Sofuoglu","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1124\/jpet.111.188425_bib40","series-title":"Manual for the Stait Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1124\/jpet.111.188425_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1471-4159.2001.00484.x","article-title":"Presynaptic autoreceptors in the third decade: focus on \u03b12-adrenoceptors","volume":"78","author":"Starke","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.188425_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/jpet.111.188425_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-006-0576-z","article-title":"The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"189","author":"Tancer","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.24895","article-title":"Oral cocaine: plasma concentrations and central effects","volume":"200","author":"Van Dyke","year":"1978","journal-title":"Science"},{"key":"10.1124\/jpet.111.188425_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00213-003-1509-8","article-title":"On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization","volume":"169","author":"Vanderschuren","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-59-1-151","article-title":"Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man","volume":"59","author":"Veith","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.111.188425_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.188425_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","article-title":"Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase","volume":"73","author":"White","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.111.188425_bib49","series-title":"SKID-I: Strukturiertes Klinisches Interview f\u00fcr DSM-IV","author":"Wittchen","year":"1997"},{"key":"10.1124\/jpet.111.188425_bib50","series-title":"Die Beschwerden-Liste, M\u00fcnchener Informationssystem","author":"Zerssen","year":"1976"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.188425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:41:46Z","timestamp":1740001306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0022356524467190"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.188425","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the \u03b12-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.188425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}